Pipeline

Prous Institute has an active and varied pipeline of therapeutics originated by our in silico systems, SYMMETRY, and developed and validated experimentally. Our compounds are at a preclinical stage and are available for discovery partnerships and collaborations.

  • Condition
  • Compound
  • Target / Action
  • Symmetry
  • Lead Discovery
  • Lead Optimization
  • Preclinical Development
  • Clinical Development

  • Depression
  • JRP 362, JRP 227
  • Monoamine Uptake / Inhibitor

Prous Institute has an active and varied pipeline of therapeutics originated by our in silico systems and developed and validated experimentally. Our compounds are at a preclinical stage and are available for discovery partnerships and collaborations.